International standards for IgG and IgM anti-β2glycoprotein antibody measurement

R. Willis, C. Grossi, M. Orietta Borghi, G. Martos-Sevilla, I. Zegers, J. Sheldon, P. L. Meroni

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

International standards for anti-beta2 glycoprotein I (anti-β2GPI) testing are needed. We evaluated the suitability of polyclonal/monoclonal candidate reference materials (RM) for the assay. IgG/IgM anti-β2GPI were affinity-purified (AP) from high-positive antiphospholipid syndrome sera and IgG from HCAL clone supernatant. Igs were tested for purity by SDS-PAGE, pooled, concentrated, sterile-filtered and the protein concentration determined. One unit was defined as the binding activity of 1-μg/ml of AP anti-β2GPI Ig. IgG/IgM RM were each assigned a unit value using the respective AP material as a calibrator. Polyclonal/monoclonal RM and 30 samples were evaluated for linearity, unit equivalency and commutability. Polyclonal AP material was assigned a value of 100 U IgG and 15-U IgM anti-β2GPI, respectively. IgG-RM had a value of 270 IgG and the IgM-RM of 220.3 IgM anti-β2GPI U. The linearity (R2) of each RM curve for the various assays ranged from 0.96 to 0.99. Commutability samples fit very well within 95% prediction intervals and had excellent correlation when comparing assays. IgG and IgM polyclonal and IgG monoclonal RM displayed excellent linearity and commutability, being good candidates for better standardization of anti-β2GPI immunoassays.

Original languageEnglish
Pages (from-to)1317-1319
Number of pages3
JournalLupus
Volume23
Issue number12
DOIs
Publication statusPublished - Oct 8 2014

Fingerprint

beta 2-Glycoprotein I
Immunoglobulin M
Anti-Idiotypic Antibodies
Immunoglobulin G
Antiphospholipid Syndrome
Immunoassay
Polyacrylamide Gel Electrophoresis
Clone Cells
Serum

Keywords

  • Anti-β2glycoprotein I antibodies
  • reference materials
  • standardization

ASJC Scopus subject areas

  • Rheumatology
  • Medicine(all)

Cite this

International standards for IgG and IgM anti-β2glycoprotein antibody measurement. / Willis, R.; Grossi, C.; Orietta Borghi, M.; Martos-Sevilla, G.; Zegers, I.; Sheldon, J.; Meroni, P. L.

In: Lupus, Vol. 23, No. 12, 08.10.2014, p. 1317-1319.

Research output: Contribution to journalArticle

Willis, R. ; Grossi, C. ; Orietta Borghi, M. ; Martos-Sevilla, G. ; Zegers, I. ; Sheldon, J. ; Meroni, P. L. / International standards for IgG and IgM anti-β2glycoprotein antibody measurement. In: Lupus. 2014 ; Vol. 23, No. 12. pp. 1317-1319.
@article{3f146eb480864044890d8995fde58c2b,
title = "International standards for IgG and IgM anti-β2glycoprotein antibody measurement",
abstract = "International standards for anti-beta2 glycoprotein I (anti-β2GPI) testing are needed. We evaluated the suitability of polyclonal/monoclonal candidate reference materials (RM) for the assay. IgG/IgM anti-β2GPI were affinity-purified (AP) from high-positive antiphospholipid syndrome sera and IgG from HCAL clone supernatant. Igs were tested for purity by SDS-PAGE, pooled, concentrated, sterile-filtered and the protein concentration determined. One unit was defined as the binding activity of 1-μg/ml of AP anti-β2GPI Ig. IgG/IgM RM were each assigned a unit value using the respective AP material as a calibrator. Polyclonal/monoclonal RM and 30 samples were evaluated for linearity, unit equivalency and commutability. Polyclonal AP material was assigned a value of 100 U IgG and 15-U IgM anti-β2GPI, respectively. IgG-RM had a value of 270 IgG and the IgM-RM of 220.3 IgM anti-β2GPI U. The linearity (R2) of each RM curve for the various assays ranged from 0.96 to 0.99. Commutability samples fit very well within 95{\%} prediction intervals and had excellent correlation when comparing assays. IgG and IgM polyclonal and IgG monoclonal RM displayed excellent linearity and commutability, being good candidates for better standardization of anti-β2GPI immunoassays.",
keywords = "Anti-β2glycoprotein I antibodies, reference materials, standardization",
author = "R. Willis and C. Grossi and {Orietta Borghi}, M. and G. Martos-Sevilla and I. Zegers and J. Sheldon and Meroni, {P. L.}",
year = "2014",
month = "10",
day = "8",
doi = "10.1177/0961203314544535",
language = "English",
volume = "23",
pages = "1317--1319",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "12",

}

TY - JOUR

T1 - International standards for IgG and IgM anti-β2glycoprotein antibody measurement

AU - Willis, R.

AU - Grossi, C.

AU - Orietta Borghi, M.

AU - Martos-Sevilla, G.

AU - Zegers, I.

AU - Sheldon, J.

AU - Meroni, P. L.

PY - 2014/10/8

Y1 - 2014/10/8

N2 - International standards for anti-beta2 glycoprotein I (anti-β2GPI) testing are needed. We evaluated the suitability of polyclonal/monoclonal candidate reference materials (RM) for the assay. IgG/IgM anti-β2GPI were affinity-purified (AP) from high-positive antiphospholipid syndrome sera and IgG from HCAL clone supernatant. Igs were tested for purity by SDS-PAGE, pooled, concentrated, sterile-filtered and the protein concentration determined. One unit was defined as the binding activity of 1-μg/ml of AP anti-β2GPI Ig. IgG/IgM RM were each assigned a unit value using the respective AP material as a calibrator. Polyclonal/monoclonal RM and 30 samples were evaluated for linearity, unit equivalency and commutability. Polyclonal AP material was assigned a value of 100 U IgG and 15-U IgM anti-β2GPI, respectively. IgG-RM had a value of 270 IgG and the IgM-RM of 220.3 IgM anti-β2GPI U. The linearity (R2) of each RM curve for the various assays ranged from 0.96 to 0.99. Commutability samples fit very well within 95% prediction intervals and had excellent correlation when comparing assays. IgG and IgM polyclonal and IgG monoclonal RM displayed excellent linearity and commutability, being good candidates for better standardization of anti-β2GPI immunoassays.

AB - International standards for anti-beta2 glycoprotein I (anti-β2GPI) testing are needed. We evaluated the suitability of polyclonal/monoclonal candidate reference materials (RM) for the assay. IgG/IgM anti-β2GPI were affinity-purified (AP) from high-positive antiphospholipid syndrome sera and IgG from HCAL clone supernatant. Igs were tested for purity by SDS-PAGE, pooled, concentrated, sterile-filtered and the protein concentration determined. One unit was defined as the binding activity of 1-μg/ml of AP anti-β2GPI Ig. IgG/IgM RM were each assigned a unit value using the respective AP material as a calibrator. Polyclonal/monoclonal RM and 30 samples were evaluated for linearity, unit equivalency and commutability. Polyclonal AP material was assigned a value of 100 U IgG and 15-U IgM anti-β2GPI, respectively. IgG-RM had a value of 270 IgG and the IgM-RM of 220.3 IgM anti-β2GPI U. The linearity (R2) of each RM curve for the various assays ranged from 0.96 to 0.99. Commutability samples fit very well within 95% prediction intervals and had excellent correlation when comparing assays. IgG and IgM polyclonal and IgG monoclonal RM displayed excellent linearity and commutability, being good candidates for better standardization of anti-β2GPI immunoassays.

KW - Anti-β2glycoprotein I antibodies

KW - reference materials

KW - standardization

UR - http://www.scopus.com/inward/record.url?scp=84908673890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908673890&partnerID=8YFLogxK

U2 - 10.1177/0961203314544535

DO - 10.1177/0961203314544535

M3 - Article

C2 - 25228737

AN - SCOPUS:84908673890

VL - 23

SP - 1317

EP - 1319

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 12

ER -